Kenya to put 650 TB patients on new drugs


The drugs bedaquiline and delamanid have been associated with higher rates of survival for those suffering from tuberculosis. Used in the United States for nearly a decade, these drugs are now making their debut in other parts of the world to treat those with drug-resistant tuberculosis and multi-drug resistant tuberculosis.

Related Stories